Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Puran Chen, Gunnar Söderdahl, Anders Österborg, David Wullimann, Jan Vesterbacka,

EBioMedicine · 2021 · 219 citations · 20 references

DOIFull text

Open access

Concepts

References

20